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The fidelity of yeast RNA polymerase II (Pol II) was assessed in vivo
with an assay in which errors in transcription of can1–100, a
nonsense allele of CAN1, result in enhanced sensitivity to the toxic
arginine analog canavanine. The Pol II accessory factor TFIIS has
been proposed to play a role in transcript editing by stimulating the
intrinsic nuclease activity of the RNA polymerase. However, dele-
tion of DST1, the gene encoding the yeast homolog of TFIIS, had
only a small effect on transcriptional fidelity, as determined by this
assay. In contrast, strains containing a deletion of RPB9, which
encodes a small core subunit of Pol II, were found to engage in
error-prone transcription. rpb9 strains also had increased steady-
state levels of can1–100 mRNA, consistent with transcriptional
errors that decrease the normal sensitivity of the can1–100 tran-
script to nonsense-mediated decay, a pathway that degrades
mRNAs with premature stop codons. Sequences of cDNAs from
rpb9 strains confirmed a significantly increased occurrence of
transcriptional substitutions and insertions. These results suggest
that Rpb9 plays an important role in maintaining transcriptional
fidelity, whereas TFIIS may serve a different primary purpose.
misincorporation  proofreading  yeast
Many DNA polymerases possess 3–5 exonuclease activitywith an important role in the fidelity of DNA synthesis.
This ‘‘proofreading’’ exonuclease excises nucleotides that have
been added to the nascent DNA chain but do not correctly match
the template base. Mutations that disable or eliminate the
nuclease activities of DNA polymerases have demonstrated the
importance of exonucleolytic proofreading to DNA replication
fidelity. In cells harboring a nuclease-deficient DNApolymerase,
the frequency of both base substitution and frameshift mutations
can be substantially increased (ref. 1 and references therein).
Interest in the possibility of an analogous proofreading mech-
anism during transcription was raised when multisubunit RNA
polymerases were shown to have a nuclease activity that cleaves
single nucleotides and short oligonucleotides from the 3 ends of
nascent RNAs (reviewed in ref. 2). The nuclease activity is
intrinsic to RNA polymerases but in some cases can be stimu-
lated by accessory proteins. The best characterized of such
stimulatory proteins are GreA and GreB for Escherichia coli
RNA polymerase and TFIIS (or SII) for eukaryotic RNA
polymerase (Pol) II, the nuclear enzyme that synthesizes mR-
NAs. Both the Gre proteins and TFIIS have been proposed to
participate directly in the nuclease mechanism by providing two
carboxylic acid side chains that might help coordinate an essen-
tialMg2 ion and position the nucleophilic water molecule (3–6).
Consistent with a possible physiological role in transcriptional
proofreading, both TFIIS andGreA are able to promote removal
of misincorporated nucleotides in vitro (7–9).
Less is known about the RNA polymerase residues that
contribute to either the intrinsic or the factor-stimulated nucle-
ase activities. Several lines of investigation have identified an
important, although largely uncharacterized, role for a small
integral Pol II subunit, Rpb9, in transcript cleavage. Rpb9-
deficient Pol II was shown to be less able to respond to
stimulation of transcript cleavage by TFIIS in vitro and to
generate different cleavage products than wild-type Pol II (10).
The Rpb9 subunit is highly conserved among eukaryotes.
Indeed, the human homolog can correct the growth defects due
to loss of Rpb9 in yeast (11). Although nonessential in yeast, the
subunit is required for viability in Drosophila (12). The other
nuclear RNA polymerases, Pol I and Pol III, also have Rpb9
counterparts. Rpc11, the corresponding Pol III subunit, is
required for the intrinsic nuclease activity of that enzyme in both
Saccharomyces cerevisiae and Schizosaccharomyces pombe (13,
14). In addition, the nuclease activity of archaeal RNA poly-
merase is mediated by a small polypeptide that is clearly related
to the eukaryotic Rpb9 family of subunits, although it is less clear
whether the archaeal polypeptide, TFS, should be considered a
core polymerase subunit or a dissociable accessory factor (15).
Like TFIIS, TFS has been shown to improve transcription
fidelity in vitro (16). Intriguingly, all of these polypeptides share
a conserved zinc ribbon domain with considerable sequence
similarity to the zinc ribbon domain of TFIIS that contains the
essential catalytic Asp–Glu dipeptide. The mechanistic role of
the zinc domain is not yet clear for the polymerase subunits,
although a mutation of one or both of the conserved carboxylic
acids of Rpc11 eliminated the nuclease activity of S. pombe Pol
III in vitro (14) and inactivated an essential function of the S.
cerevisiae subunit in vivo (13).
Although TFIIS is an obvious candidate for a role in tran-
scriptional proofreading by Pol II in vivo, other eukaryotic RNA
polymerases presumably must rely on their intrinsic nuclease
activities if they are to proofread the nascent transcripts. Indeed,
it is possible that the intrinsic nuclease activity might suffice for
Pol II as well, because we have shown that Pol II can remove a
misincorporated nucleotide during rapid chain extension in vitro
even in the absence of TFIIS, although the efficiency was higher
when TFIIS was present (7).
To determine whether the intrinsic andor TFIIS-promoted
nuclease activity of Pol II contributes to the fidelity of mRNA
synthesis in the cell, we developed an assay with which we can
detect changes in Pol II transcriptional fidelity in S. cerevisiae.
Using this assay, we demonstrated that the loss of the Rpb9
subunit significantly reduced transcriptional accuracy in vivo,
whereas deletion of the gene encoding TFIIS had a much more
modest effect.
Results and Discussion
Assay for Transcriptional Fidelity in Vivo. We designed our tran-
scriptional accuracy assay system to have the following essential
characteristics: an easily scored phenotype, very high sensitivity,
and a very low background from translational errors. Previous
assays for transcriptional errors have monitored transcriptional
correction of premature stop codons in an upstream region of a
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reporter gene (17–19). However, a relatively high frequency of
translational read-through of nonsense codons can confound
such analyses (18). To avoid this problem, we modeled our
system after an assay successfully used to isolate decreased
fidelity mutants of E. coli RNA polymerase (17). That screen
used a highly polar nonsense mutation within the lacZ coding
sequence. When this mutant allele was accurately transcribed,
the lacZ transcripts were truncated by premature transcription
termination. By this means, the background of -galactosidase
production due to translational read-through of the stop codon
was depressed sufficiently that the rare transcriptional errors by
mutant RNA polymerases could be detected. The decreased
accuracy of those polymerase variants was demonstrated in vitro
(17), validating the assumptions inherent in the design of the
screen.
The nonsense-mediated decay (NMD) pathway may be the
eukaryotic counterpart of the prokaryotic phenomenon of tran-
scriptional polarity. The NMD pathway in yeast has been shown
to promote rapid degradation of RNAs containing premature
stop codons (reviewed in refs. 20 and 21). Not every premature
stop codon promotes rapid degradation of the mRNA. Instead,
other signals, as yet poorly understood, are required to trigger
the response (20). For our fidelity assay, we used a gene with an
easily scored phenotype for which a premature nonsense codon
had been shown to promote rapid degradation of the mRNA. In
this way, we could be confident that RNAs that were faithfully
transcribed by Pol II (and therefore contained the stop codon
and any other signals required for NMD) would be rapidly
degraded. RNAs that had lost the stop codon or other NMD-
related sequence information because of a transcriptional error
would be stabilized and contribute to production of the protein
product. A well characterized allele of the CAN1 gene fulfilled
these criteria.
The CAN1 gene encodes a high-affinity permease that trans-
ports arginine into cells (22). Canavanine is a toxic arginine
analog that is also transported by Can1. can1–100 has an A-to-T
mutation at codon 47, changing AAA (Lys) to UAA (Stop) (23).
Growth inhibition of CAN1 cells by canavanine can be detected
at concentrations as low as 1 gml, whereas can1–100 cells are
resistant to high concentrations (at least 300 gml). However,
in the absence of a functional NMD pathway, infrequent trans-
lational read-through of the nonsense codon produces enough
Can1 to render the can1–100 cells sensitive to relatively low
concentrations of canavanine (30 gml) (ref. 23; also, see Fig.
2). Together, these observations demonstrated that the can1–100
allele has the essential characteristics for an assay to detect rare
transcriptional errors: low background levels due to translation
errors and very high sensitivity. Any transcriptional errors that
stabilized the can1–100mRNA against NMD might be expected
to contribute to Can1 production, observable as an increase in
canavanine sensitivity, by increasing the steady-state level of
the transcript. The expectations for our assay are summarized in
Fig. 1.
We constructed a set of yeast strains with the can1–100 allele
at the chromosomal CAN1 locus and verified that the canava-
nine-resistant phenotype of these strains was suppressible by a
suppressor tRNA (data not shown). To test the importance of
TFIIS to transcriptional fidelity, we deleted the DST1 gene,
which encodes the yeast TFIIS homolog. We also deleted the
RPB9 gene, which encodes a nonessential Pol II subunit. In vitro,
Rpb9 contributes to the nuclease activity of Pol II and is required
for efficient recognition of pause and arrest sites at which
cleavage takes place (10).
Rpb9 Increases Transcriptional Fidelity Independent of TFIIS. Fig. 2a
shows an experiment comparing the canavanine sensitivities of
the wild-type, dst1, and rpb9 can1–100 strains. Although loss
of the DST1 gene caused a small increase in sensitivity (observ-
able at 300 gml canavanine), deletion of the RPB9 gene had
a very large effect, conferring sensitivity to as little as 50 gml
canavanine. The observed canavanine sensitivity was entirely
dependent on expression of the can1–100 allele, because can1
cells were completely resistant to 300 gml canavanine, inde-
pendent of the presence of TFIIS or Rpb9 (data not shown).
These results are consistent with an important role forRPB9, and
perhaps to a lesser extent DST1, in Pol II transcription fidelity.
We considered the possibility that increased sensitivity to
canavanine in the experiment of Fig. 2a resulted indirectly from
decreased levels of intracellular arginine rather than directly
from increased levels of the Can1 transporter. Published mi-
croarray data showed that the deletion of RPB9 has little effect
on global gene expression; however, the level of ARG1 tran-
scripts in an rpb9 strain was reduced to half of that observed for
wild-type cells (24). We supplied an additional copy of ARG1 on
a centromere-based plasmid in the rpb9 can1–100 cells and
observed no effect on canavanine sensitivity (data not shown).
This result provides further support that increased canavanine
sensitivity in our assay reflects an increased frequency of tran-
scriptional errors in the can1–100 gene, resulting in increased
Can1 production.
We designed our assay based on the assumption that NMD-
mediated degradation of can1–100 mRNAs would be required
for detection of rare transcriptional errors above the background
of translational errors. To test the validity of this assumption, we
inactivated the NMDpathway by deletingNMD2 in the can1–100
strains (Fig. 2b). Cells lacking NMD2 failed to grow on 40 gml
Fig. 1. Design of assay for transcriptional accuracy in vivo. Rare transcrip-
tional errors by an error-prone Pol II correct the premature stop codon andor
stabilize the can1–100 mRNA to NMD, allowing increased production of Can1
protein, which is detected as enhanced sensitivity to canavanine.
Fig. 2. Contributions of TFIIS, Rpb9, and the NMD pathway to canavanine
sensitivity. (a) Mid-log phase cultures of the various yeast strains were serially
diluted to equal concentrations and spotted onto synthetic complete medium
lacking arginine and containing the indicated concentrations of canavanine.
Growth was evaluated after 2 days. (b) Same as in a for the indicated strains,
except that growth was evaluated after 4 days.
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canavanine, even in the presence of the wild-type RPB9 allele.
Thus, potential effects of error-prone transcription resulting
from deletion of RPB9 were impossible to detect in the absence
of a functional NMD pathway. Maderazo et al. (23) showed that
deletion of NMD2 increased arginine import activity 2.5-fold
compared with that measured for an otherwise isogenic can1–
100 strain. The loss of canavanine resistance in the nmd2 strain,
proposed to result primarily from translational read-through of
the stop codon (23), illustrates the high level of sensitivity of this
assay. Transcriptional errors either eliminating the stop codon or
stabilizing the mRNA to NMD would reasonably be expected to
occur at even lower frequency than translational read-through.
Consistent with that expectation, the rpb9 strain with a wild-
type NMD pathway was only partially sensitive to 40 gml
canavanine (Fig. 2b).
If, as hypothesized, sensitivity to canavanine in the rpb9
strain were due to transcriptional errors that stabilized the RNA
against NMD, we would expect to observe a higher steady-state
level of can1–100 transcripts in rpb9 cells than in the other
strains. To test this prediction, we isolated RNA from CAN1 and
can1–100 strains and used both Northern analysis (Fig. 3) and
real-time PCR to measure transcript levels. The results of the
two assays were very similar (Table 1). In the CAN1 strains,
deletion of either RPB9 or DST1 did not affect the transcript
levels, which were the same within experimental error for the
three strains. As expected, each strain showed a reduction in
transcript levels when the CAN1 allele was replaced with can1–
100. The magnitude of reduction due to the can1–100 mutation
in the DST1RPB9 strain background is consistent with the
reported magnitude of destabilization of the can1–100 transcript
by the NMD pathway (23).
Absence of TFIIS had little effect on the abundance of
can1–100 transcripts. Although we observed a small increase in
can1–100 transcript levels for the dst1 strain compared with the
isogenic DST1 strain in three of five Northern blot experiments,
the difference was within the experimental error. Indeed, it may
not be possible to detect such a minor difference in transcript
levels with a high level of confidence. In contrast, the can1–100
transcript was reproducibly more abundant in the rpb9 back-
ground. This result supports the hypothesis that a population of
can1–100 transcripts was stabilized in rpb9 cells by transcrip-
tional errors that eliminated the stop codon andor reduced the
signal for NMD.
Error Frequency of Rpb9-Deficient Pol II. To compare the frequency
of transcriptional errors in the rpb9 and RPB9 yeast, we
sequenced individual cDNAs synthesized from RNA obtained
from these two strain backgrounds. We tabulated all errors
observed within an 450-base segment of the CAN1 RNA. We
found a significantly higher incidence of both substitution and
insertion errors for the rpb9 strains, consistent with the pro-
posed decrease in transcriptional accuracy (Table 2). Both types
of errors were widely distributed, with no pronounced hotspots
(Fig. 5, which is published as supporting information on the
PNAS web site).
We observed an overall frequency of 1.3  103 misincorpo-
rations per base pair for cDNAs prepared from RNAs isolated
from the RPB9 strain. This value, although consistent with some
previous estimates of RNA polymerase accuracy (25, 26), is
likely to be an overestimate of the true error frequency of
wild-type Pol II, because the number includes the unknown
background of errors introduced during double-stranded
cDNA synthesis. Although the reported error frequencies for
the reverse transcriptase and DNA polymerase used to prepare
the cDNA are more than two orders of magnitude lower
than the value we observed (27, 28), we have no way to determine
the actual error rate in our experiments. However, if we assume
that errors introduced during cDNA synthesis occurred at a
similar frequency for both strains, then the observed difference
in misincorporation frequency of the two strains (four substitu-
tions for every 10,000 nucleotides incorporated) can be attrib-
uted to the loss of Rpb9.
Although Pol II made fewer frameshift errors than base
substitutions in both strain backgrounds (Table 2), insertions
constituted a significantly higher proportion of the total errors
in the strains lacking Rpb9 (30 of 190 or 16% compared with
6 of 107 or 6% for the RPB9 strain). In this respect, the rpb9
Pol II resembles DNA polymerases depleted of their proofread-
ing exonuclease activities. An increase in the ratio of frameshift-
to-substitution errors upon loss of proofreading capability ap-
pears to be a general property of DNA polymerases, whereas the
distribution of frameshifts between deletions and insertions can
vary with different DNA polymerases (1).
Our finding that the number of substitution and frameshift
errors was significantly increased in the rpb9 strain is consistent
with the proposal that transcriptional errors that interfered with
NMD were responsible for the higher steady-state level of
can1–100 RNA observed for the same strain. NMD could be
inhibited either by base substitutions in important sequences,
including the nonsense codon itself, or by frameshift errors
upstream of the nonsense codon, although the latter class of
transcripts would not be expected to produce active Can1.
The sequences required for NMD-mediated degradation of
can1–100 transcripts have not been determined, and our
sequencing analysis did not address this issue. As discussed
above, we cannot be certain which substitution errors were
introduced by Pol II rather than by the other polymerases used
in preparation of the cDNAs. In addition, we cannot assume
that the sequenced cDNAs represented only the stabilized
population of can1–100 mRNAs. We cloned relatively short
cDNAs representing an internal region of the ORF, and it is
possible that transcripts in the process of being degraded were
able to serve as templates for cDNA synthesis. Nevertheless,
this analysis has definitively shown that the lack of Rpb9 leads
to an increase in the types of errors that would be expected to
interfere with NMD.
Fig. 3. Northern blot of CAN1 transcripts. Total RNA was isolated from the
indicated strains and processed as described in Materials and Methods.
Table 1. Quantification of CAN1 transcript levels in can1–100 and
CAN1 strains
Strains being compared
Ratio of CAN1 transcript levels
Northern blots Real-time PCR
dst1can1–100DST1can1–100 1.2  0.2 1.1  0.2
rpb9can1–100RPB9can1–100 1.7  0.1 1.6  0.1
CAN1can1–100 2.9  0.8 3.5  0.4
In the real-time PCR assays, the CAN1 transcript levels were normalized to
tubulin (TUB3) mRNA for each strain. The transcript levels in the Northern blot
experiments were normalized to 28S rRNA. Data in the table are mean values
from five Northern blot and seven RT-PCR experiments.
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Distinct Roles of Rpb9 and TFIIS. These experiments provide strong
evidence that the Rpb9 subunit of Pol II has an important role
in assuring the fidelity of transcription in vivo. In contrast, TFIIS
appeared to be less important, although the small increases in
canavanine sensitivity and transcript levels observed for the
dst1 strain may represent a real decrease in transcriptional
fidelity compared with the wild-type strain.
The NMD pathway is thought to mitigate deleterious effects
of defective transcripts, which might code for dominant-negative
proteins or interfere with other cellular processes (21). A general
loss of transcriptional fidelity would be expected to increase the
production of defective transcripts subject to NMD surveillance,
making that pathway more important to cell viability. Consistent
with that hypothesis, we observed that an RPB9 deletion reduced
the viability of nmd2 yeast on minimal media (Figs. 2b and 4).
In contrast, deletion of the DST1 gene did not decrease the
viability of nmd2 yeast strains (Fig. 4), supporting the conclu-
sion that, under normal growth conditions, Rpb9 has a more
important role than TFIIS in maintaining accurate transcription.
That interpretation is also consistent with conclusions of two
previous studies addressing the role of TFIIS in transcriptional
proofreading in S. cerevisiae. In one case, Reines and coworkers
(18) used a nonsense codon in the luciferase gene to assess
transcriptional fidelity but found that the background from
translational errors limited the ability to detect a low frequency
of transcriptional errors. They concluded that any role of TFIIS
must be relatively small, in that it could not be detected above
the background. In the other study, Koyama et al. (19) found that
the absence of TFIIS increased the production of -galactosi-
dase from a nonsense allele of the lacZ gene under conditions
of oxidative stress. They concluded that TFIIS has a role in
excising oxidized nucleotides from the nascent transcript. In the
absence of oxidative stress, the contribution of TFIIS to lacZ
production in this assay was minimal. Consistent with that
finding, chromatin immunoprecipitation analysis has shown that
TFIIS becomes widely associated with transcribed sequences
only under stress conditions (29), suggesting a relatively special-
ized role for TFIIS in vivo.
The previous lack of an in vivo assay for Pol II transcriptional
fidelity has resulted in a reliance on biochemical studies in vitro
to identify possible mechanisms for maintaining accuracy. The
well characterized role of TFIIS in stimulating the nuclease
activity of Pol II (reviewed in ref. 2) suggested that TFIIS could
increase fidelity by stimulating a proofreading nuclease that
selectively removes mismatched nucleotides from the nascent
transcript. Indeed, we have shown that, in vitro, the TFIIS-
stimulated nuclease activity can effectively proofread under
conditions of rapid chain elongation (7).
A compelling model for the molecular mechanism of TFIIS
action was provided by the crystal structure of the Pol II–TFIIS
complex (3), in which a zinc ribbon domain of TFIIS inserts into
the active site of Pol II. This domain includes two acidic amino
acids that are thought to coordinate a Mg2 ion and position a
water molecule to serve as the nucleophile in RNA hydrolysis.
Our finding that TFIIS plays at most a minor role in tran-
scription accuracy under favorable growth conditions suggests
that, although it can perform a proofreading function in vitro, it
generally does not do so in vivo. One possible explanation is that
TFIIS does not associate with the elongation complex in vivo to
a sufficient extent or with fast enough kinetics to be useful for
proofreading simple mismatches. Perhaps the intracellular con-
centration of TFIIS is too low or the elongation complex with a
mismatched nucleotide is not an optimal substrate for TFIIS
binding or activity. In vitro, TFIIS can promote transcript
cleavage in elongation complexes stalled for a variety of reasons,
but transcripts associated with arrested elongation complexes
appear to be most rapidly cleaved. Arrest is a conformational
rearrangement of the elongation complex in which the polymer-
ase slides upstream along both the nascent transcript and the
DNA, displacing the 3 end of the RNA from the catalytic site
(30, 31). Although arrest might occur after incorporation of a
mismatched nucleotide, the arrest propensity at a particular
position would be expected to be sequence-specific (32). We
have previously shown that human Pol II did not arrest after
incorporating a mismatched nucleotide at the sites that we
investigated in vitro (7).
In the absence of arrest, the intrinsic nuclease activity of Pol
II might be better suited to remove the 3 nucleotide. Consistent
with that idea, we have found that Rpb9-deficient yeast strains
have enhanced sensitivity to cordycepin (3-deoxyadenosine)
(data not shown), which is converted into a chain-terminating
nucleoside triphosphate in yeast (33). RNA elongation after
incorporation of this chain terminator requires nucleolytic ex-
cision, and the enhanced sensitivity may be another indicator of
defective proofreading activity. Interestingly, TFIIS-deficient
strains show no increase in cordycepin sensitivity relative to
wild-type yeast (data not shown).
An in vitro analysis of a potential role for Rpb9 in transcrip-
tional fidelity has not been reported. However, it has been shown
that Rpb9 is required for optimal stimulation of cleavage activity
by TFIIS (10). Crystal structures of Pol II alone or assembled in
an elongation complex (34, 35) provide little basis for deducing
a potential role for Rpb9 in either the TFIIS-stimulated or
intrinsic nuclease activity. Although parts of both proteins
interact with Pol II in the structural feature known as the ‘‘jaw,’’
Fig. 4. Effect of absence of the NMD pathway on growth of yeast lacking
TFIIS or Rpb9. Mid-log phase cultures of the indicated yeast strains were
serially diluted and spotted onto synthetic complete medium. Growth was
evaluated after 2 days.
Table 2. Types and frequencies of sequence errors in cDNAs from RPB9 and rpb9  yeast
Strain
Base
substitutions
Fraction
transversions
No. of
deletions
No. of
insertions
Total
errors
No. of
nucleotides
sequenced
Substitution
frequency
(103)
Insertion
frequency
(103)
Overall error
frequency
(103)
RPB9 97 0.16 4 6 107 73,632 1.3 0.08 1.4
rpb9 156 0.15 4 30 190 92,933 1.7 0.32 2.0
cDNAs were prepared from total RNA isolated from the indicated yeast strains and cloned into a bacterial plasmid. DNA from individual bacterial colonies
was sequenced. Statistical analysis of the data showed that the probabilities that the observed differences in the substitution and insertion frequencies were
not due to chance were 97% and 99%, respectively.
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there is no apparent direct interaction between TFIIS and Rpb9.
Consistent with that conclusion, the affinity of the association of
TFIIS with Pol II is not altered by the absence of Rpb9 (10).
Furthermore, there is no direct presence of any part of Rpb9
near the Pol II active site, nor does Rpb9 appear to interact
directly with the DNA template or RNA transcript. It does bind,
by means of its C-terminal zinc ribbon domain, to residues on the
exterior surface of a structural feature called the funnel. The
funnel surrounds a pore through which the 3 end of the RNA
is thought to extrude when Pol II arrests. TFIIS infiltrates the
catalytic site through this pore (3).
Mechanisms by Which Rpb9 May Affect Transcriptional Fidelity. We
have considered three potential mechanisms by which Rpb9
might enhance transcriptional fidelity. First, Rpb9 may affect
discrimination of the correct nucleotide during chain elongation.
Such discrimination could be related to the relative rates of
incorporation of the templated nucleotide versus an incorrect
nucleotide. We have shown that these rates can differ by
500-fold in vitro (7). It is possible that Rpb9 has a significant
impact on the overall geometry of the active site, although the
crystal structures do not provide any insight into how this might
occur. Alternatively, discrimination could relate to rates of chain
extension after incorporation of a correct versus an incorrect
nucleotide. The rate of extension from a correctly templated
nucleotide is 15- to 20-fold faster than when the 3 end of the
nascent transcript is mismatched (7). Presumably, this slower
rate provides time for proofreading before elongation. The
observed increased overall rate of elongation of Rpb9-deficient
Pol II in vitro (10) could be consistent with decreased kinetic
preferences for incorporation of correct versus incorrect nucle-
otides or for extension of base-paired versus mismatched 3 ends.
A second possible role of Rpb9 in transcriptional fidelity is in
mediating interaction between Pol II and other components of
the transcription machinery. Lack of an in vivo assay has
precluded the use of genetic screens to identify genes that affect
fidelity, so almost nothing is known about what factors might be
involved. It is possible that chromatin structure or elongation
factors may play a major role, and the position of Rpb9 at the
leading edge of the elongating polymerase hints that interactions
between Pol II and other proteins may occur through Rpb9.
Consistent with this general idea, deletion ofRPB9 is lethal when
combined with deletions of genes encoding some components of
the chromatin remodeling complex SAGA (Spt-Ada-Gcn5
acetyltransferase) and the elongation complex Elongator (36),
and the Spt7 component of SAGA is a two-hybrid partner with
Rpb9 (37).
A third mechanism by which Rpb9 could enhance fidelity is by
contributing to an intrinsic Pol II proofreading nuclease. We
argue that this possibility is the most parsimonious view at
present, based on what is known about the properties and
functions of Rpb9 and the related subunits of Pol III (Rpc11)
and Pol I (Rpa12). We have previously shown that the intrinsic
nuclease activity of human Pol II is capable of postinsertion error
correction of a misincorporated nucleotide in vitro (7). Rpb9 has
not yet been demonstrated to contribute to the intrinsic nuclease
activity of Pol II, but it clearly is required for optimal function
of TFIIS (10). Rpb9 was reported to be dispensable for the
intrinsic nuclease activity, because depletion of Rpb9 was shown
not to reduce the transcript cleavage observed in Pol II com-
plexes at elevated pH (10, 38). However, it is possible that the
elevated pH altered the mechanism of cleavage in these studies,
because the hydroxyl ions may catalyze the reaction directly (38).
The Rpc11 subunit of Pol III has been shown to be essential
for the intrinsic nuclease activity of that polymerase (13), and
mutational analysis has suggested a functional relationship be-
tween loss of nuclease activity and other observed behaviors of
the polymerase, some of which are shared by Pol II lacking Rpb9.
For example, Pol III lacking Rpc11 responded inefficiently to
normal transcriptional pause sites in vitro (13), a property also
observed for Pol II lacking Rpb9 (10). In addition, an rpc11
mutation in S. pombe that impaired the nuclease activity of Pol
III conferred hypersensitivity to 6-azauracil (14), as did deletion
of the S. cerevisiae rpa12 gene encoding the homologous subunit
for Pol I (39). Enhanced sensitivity to 6-azauracil and mycophe-
nolic acid, which inhibit de novo nucleotide biosynthesis and
deplete nucleotide pools, is also characteristic of strains with
deletions in RPB9 and DST1 (37, 40, 41). Intriguingly, the
absence of wild-type Rpc11 led to the production of transcripts
that were one or more nucleotides longer than those synthesized
by the Rpc11-containing enzyme both in vivo (14) and in
side-by-side reactions in vitro (13, 14). This behavior, which was
also correlated with the loss of nuclease activity, may be related
to the increased frequency of transcription insertion errors
observed in the rpb9 yeast strains.
Considering these phenotypic similarities, as well as their
structural similarities, there is currently no reason to suppose
that Rpb9 and the related subunits of Pol I and Pol III have
completely different roles in their respective enzymes, although
some functional differences between the RNA polymerases,
reflecting their specific roles in the cell, are expected. The three
Rpb9-like subunits show significant sequence similarity in both
the N-and C-terminal domains, and, based on that information,
as well as a variety of structural studies, all three have been
proposed to occupy similar positions on their RNA polymerases
(3, 13, 39, 42). Based on current knowledge, it is difficult to
understand how these subunits contribute to an activity that is
thought to occur in the catalytic active site, which is30 Å from
the closest approach of Rpb9 in the existing crystal structures. It
is possible that the action is truly effected at a distance, but it is
also possible that the RNA polymerases undergo a conforma-
tional shift that brings some portion of the subunit closer to the
3 end of the RNA.
Taken together, these observations support the idea that the
decreased Pol II transcription fidelity in rpb9 yeast was due
to an altered nuclease activity that affected transcriptional
proofreading.
Materials and Methods
Yeast Strains. Yeast strains used in this study are listed in Table
3, which is published as supporting information on the PNAS
web site. The strains shown in Fig. 4 are derivatives of YPH499.
The parent of all other strains was a trp1 deletion derivative of
BY4742 (Research Genetics) constructed in the laboratory of
George Sprague (University of Oregon). The can1–100 allele
was introduced into the BY4742 background by transformation
of a PCR product derived from a can1–100 strain. The presence
of can1–100 was verified in the transformants by sequencing
DNA derived from PCR amplification of the CAN1 locus.
RNA Preparation. Total RNA was extracted from cells grown in 30
ml of yeast extract peptone dextrose complete medium to A600
of 0.4–0.6 by using the acid phenol method (43). RNA samples
were then treated with RNase-Free DNase (Stratagene) accord-
ing to the manufacturer’s protocol, extracted with phenol
chloroform, and precipitated with ethanol. RNA was resus-
pended in 0.2-m-filtered water, and the concentration was
determined by spectrophotometry. The purity and integrity of
the RNA were confirmed by agarose gel electrophoresis. Single-
use aliquots of RNA were stored at 80°C.
Northern Blot Analysis. Total RNA (10 g) was resolved on a 1.2%
(wtvol) agarose6% formaldehyde gel and blotted onto magna
nylon transfer membrane (Osmonics, Minnetonka, MN). Filters
were stained with methylene blue, and digital images of the
rRNA bands were stored to normalize for equal loading of the
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RNA. The template for the CAN1DNA probe was generated by
PCR amplification of genomic DNA. The forward primer (5-
GCATATGTACAATGAGCCGGT) and reverse primer (5-
TGGGTTTCTCCAATAACGGA) cover, respectively, posi-
tions 39–59 and 779–798 of the CAN1 gene. The 720-bp
amplicon was 32P-labeled by random priming (Klenow exo,
New England Biolabs), and the radioactively labeled probe was
hybridized to the filter at 65°C overnight in CHURCH buffer
(0.5 M NaPO4, pH 7.51 mM EDTA7% SDS). The membrane
was then exposed to a phosphor screen (Molecular Dynamics)
and scanned with a phosphoimager (STORM 860, Molecular
Dynamics).
cDNA Synthesis. cDNAs were synthesized from total RNA by
using the SuperScript II RNaseH reverse transcriptase system
(Invitrogen) and then incubated with RNase H. For real-time
PCR, cDNA synthesis was primed with random hexamers. For
cloning and DNA sequencing, a CAN1 primer hybridizing to
positions 826–846 of the ORF was used. Double-stranded DNA
corresponding to ORF nucleotides 9–798 was synthesized by one
round of PCR with High Fidelity polymerase (Roche).
Real-Time PCR. PRIMER EXPRESS software was used to design all
primer pairs for real-time PCR. These sets include a forward and
reverse primer for the CAN1 gene (5-CACTTTTGCCCTG-
GAACTTAGTG and 5-TGCCGGCAGTGGAACTTT, re-
spectively) and a pair of primers for the detection of TUB3 cDNA
levels (forward, 5-CCTGCGCCTCAATTGTCTACT; reverse,
5-TTCCAGGGTGGTATGCGTG). Quantitative real-time
PCR was done in 96-well plates by using the automated ABI
PRISM 7900HT sequence detection system. RT-PCR mixtures
were prepared in bulk as a master mix, and then aliquots were
pipetted into the individual wells. Each well was loaded with a
25-l reaction mixture containing 75 ng of template cDNA,
forward and reverse primers at 500 nM, and 12.5 l of 2
SYBRGreen PCRMaster Mix. A ‘‘no template’’ control was run
in parallel with every reaction. Fluorescence emissions were
recorded in real time at the specified wavelengths, and data were
analyzed automatically with SDS 2.0 software. The expression
data obtained represent average values from aminimum of three
replicate experiments. Unless otherwise stated, all reagents were
purchased from Applied Biosystems.
Error Rate Determination. Double-stranded cDNAs were ligated
into HindIIIEcoRI sites in pBluescriptII ks (Stratagene).
Plasmid DNA was transformed into E. coli and then isolated
from individual bacterial colonies and sequenced at the Institute
of Molecular Biology Biotechnology Laboratory (Eugene, OR).
The sequencing software program (Beckman CEQ 8000 Genetic
Analysis System SEQUENCE INVESTIGATOR) was used to evaluate
the quality of sequencing data for each possible misincorpora-
tion. Regions of sequence with confidence limits 	0.98 were
rejected; within accepted regions, sequence changes with con-
fidence limits deviating by0.05 from the neighboring positions
were not included. To determine the significance of the differ-
ences in the observed error frequencies, we calculated the z-ratio
and one-tail probability for the difference in independent
proportions.
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